The Institut Curie is a foundation of public interest, which combines one of the largest European oncology research center and two state-of-the-art hospitals. Founded in 1909 on a model devised by Marie Curie and still at the cutting edge: “from fundamental research to innovative treatments”, the Institut Curie has 3,000 researchers, physicians, clinicians, technicians and administrative staff. Through its innovative programs and the dissemination of their findings around the world, Institut Curie scientists and clinicians contribute to the development of new treatments against cancer.
The Hospital Group of the Institut Curie is a private organization which contributes to the public health system. With its diagnostic (imaging, pathology, laboratory testing) and therapeutic (surgery, radiotherapy, medical treatments, support treatment) armory, it blends technology and care, and ensures national and international dissemination of medical innovations.
A pioneer in a number of conservative treatments, the Hospital is a reference center throughout the world for breast cancer, pediatric tumors, sarcomas, eye tumors and numerous advanced techniques such as oncogenetics and precision radiotherapy (curietherapy, proton therapy).
The Research Center of the Institut Curie is one of the most important in Europe and the largest in France dedicated to cancer research. It houses more than 80 joint Institut Curie – CNRS, Inserm or University research groups whose common goal is to increase knowledge and ameliorate patient management using state-of-the-art technology platforms.
The Translational Research Department spearheads translational research and forms a vital link between basic research and healthcare, thus expediting transfer of scientific innovations from bench to bedside. It is developing new diagnostic techniques and more effective and safer approaches to treatment.
Claude Huriet is the President of the Institut Curie. Furthermore, he is a Chevalier of the Legion of Honour, and a Commander of the Order of Merit. He is a member of the International Bioethics Committee of United Nations Education Scientific and Cultural Organisation and the Biomedicine Agency; Director of the Hospital Federation of France; Vice-Chairman of Cancéropôle Ile-de-France; and Chairman of the Advisory Board and the Board of Directors at the Foundation of General Health.
Prior to his current roles, he was Chief of Nephrology and Professor Emeritus at the Faculty of Medicine within the University Hospital of Nancy, France. Previous political functions include being Senator of Meurthe-et-Moselle, and Former President of the General Council. He has also been an Honorary Senator and Honorary Member of Parliament.
Furthermore, he was Chairman of the Supervisory Board of the National Family Allowances Fund and the Regional Conference of Health; and President of both the Union Hospital Northeast and the National Compensation for Medical Accidents, Latrogenic Diseases and Nosocomial Infections. He is a former member of the National Consultative Ethics Committee for Life Sciences and Health and of the High Committee of Public Health.